British Journal of Haematology

DYSERYTHROPOIESIS AND CONGENITAL DYSERYTHROPOIETIC ANAEMIAS
pp. 785-797(13)
Author: WICKRAMASINGHE S.N.

Murine endothelial cells support fetal liver erythropoiesis and myelopoiesis via distinct interactions
pp. 798-808(11)
Authors: Ohneda O.; Bautch V.L.

Granulocyte-macrophage colony stimulating factor receptor alpha and beta chain complexes can form both high and intermediate affinity functional receptors
pp. 809-818(10)
Authors: WHEADON H.; DEVEREUX S.; KHWAJA A.; LINCH D.C.

Expression and function of receptors for extracellular matrix molecules in the differentiation of human megakaryocytes in vitro
pp. 819-827(9)
Authors: Mossuz P.; Schweitzer A.; Molla A.; Berthier R.

Antibodies to CD44 enhance adhesion of normal CD34+ cells and acute myeloblastic but not lymphoblastic leukaemia cells to bone marrow stroma
pp. 828-837(10)
Authors: Bendall L.J.; Kirkness J.; Hutchinson A.; Bianchi A.; Makrynikola V.; Bradstock K.F.; Gottlieb D.J.

Cellular effects of hydroxyurea in Hb SC disease
pp. 838-844(7)
Authors: Steinberg M.H.; Nagel R.L.; Brugnara C.

Angioid streaks are part of a familial syndrome of dyserythropoietic anaemia (CDA III)
pp. 845-849(5)
Authors: Sandstrom H.; Wahlin A.; Eriksson M.; Holmgren G.; Lind L.; Sandgren O.

Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients
pp. 850-855(6)
Authors: Telfer P.T.; Garson J.A.; Whitby K.; Grant P.R.; Yardumian A.; Hoffbrand A.V.; Wonke B.

Rapid genetic screening for haemochromatosis using heteroduplex technology
pp. 856-859(4)
Authors: Jackson H.A.; Bowen D.J.; Worwood M.

Pulsed high-dose dexamethasone in chronic autoimmune haemolytic anaemia of warm type
pp. 860-862(3)
Authors: Meyer O.; Stahl D.; Beckhove P.; Huhn D.; Salama A.

Expression of several members of the TNF-ligand and receptor family on tonsillar lymphoid B cells
pp. 863-869(6)
Authors: Durkop H.; Anagnostopoulos I.; Bulfone-Paus S.; Stein H.

Ultraviolet irradiation induces multiple DNA double-strand breaks and apoptosis in normal granulocytes and chronic myeloid leukaemia blasts
pp. 869-872(4)
Authors: Bogdanov K.V.; Chukhlovin A.B.; Zaritskey A.Y.; Frolova O.I.; Afanasiev B.V.

Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome
pp. 873-879(7)
Authors: Godeau B.; Piette J.C.; Fromont P.; Intrator L.; Schaeffer A.; Bierling P.

Characterization of P2x1 purinoreceptors on rat platelets: effect of clopidogrel
pp. 880-886(7)
Authors: Savi P.; Bornia J.; Salel V.; Delfaud M.; Herbert J.M.

Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome
pp. 887-892(6)
Authors: Lawrie A.S.; Purdy G.; Mackie I.J.; Machin S.J.

The role of compliance as a cause of instability in oral anticoagulant therapy
pp. 893-900(8)
Authors: van der Meer F.J.M.; BrieT E.; Vandenbroucke J.P.; Sramek D.I.; Versluijs M.H.P.M.; Rosendaal F.R.

Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism
pp. 901-906(6)
Authors: Morichika S.; Shima M.; Kamisue S.; Tanaka I.; Imanaka Y.; Suzuki H.; Shibata H.; Pemberton S.; Gale K.; McVey J.; Tuddenham E.G.D.; Yoshioka A.

Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3\'-untranslated region of the prothrombin gene
pp. 907-909(3)
Authors: Brown K.; Luddington R.; Williamson D.; Baker P.; Baglin T.

Severe acquired haemophilia A treated with recombinant factor VIIa
pp. 910-912(3)
Authors: Shafi T.; Jeha M.T.; Black L.; Douri M.A.; Al Douri M.

Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization
pp. 913-921(9)
Authors: Clodi K.; Younes A.; Goodacre A.; Roberts M.; Palmer J.; Younes M.; Cabanillas F.; Andreeff M.

Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia
pp. 922-926(5)
Authors: Wong K.F.; Chan J.K.C.; Kwong Y.L.

Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study
pp. 927-933(7)
Authors: Bazarbachi A.; Soriano V.; Pawson R.; Vallejo A.; Moudgil T.; Matutes E.; Peries J.; Molina A.; de The H.; Schulz T.F.; Catovsky D.; Gill P.S.

Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12
pp. 934-939(6)
Authors: Oscier D.G.; Matutes E.; Copplestone A.; Pickering R.M.; Chapman R.; Gillingham R.; Catovsky D.; Hamblin T.J.

Leukaemia presenting as marrow hypoplasia: molecular detection of the leukaemic clone at the time of initial presentation
pp. 940-844(5)
Authors: Morley A.A.; Brisco M.J.; Rice M.; Snell L.; Peng L.M.; Hughes E.; Neoh S.H.; Sykes P.J.

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X
pp. 945-951(7)
Authors: Chessells J.M.; Harrison G.; Lilleyman J.S.; Bailey C.C.; Richards S.M.

Sensitivity of human acute myeloid leukaemia to diphtheria toxin-GM-CSF fusion protein
pp. 952-959(8)
Authors: Rozemuller H.; Rombouts E.J.C.; Touw I.P.; FitzGerald D.J.P.; Kreitman R.J.; Pastan I.; Hagenbeek A.; Martens A.C.M.

Monocyte-mediated killing of human leukaemia is enhanced by administration of granulocyte-macrophage colony stimulating factor following chemotherapy
pp. 960-968(9)
Authors: Williams M.A.; Newland A.C.; Kelsey S.M.

Underestimation of inversion (16) in acute myeloid leukaemia using standard cytogenetics as compared with polymerase chain reaction: results of a prospective investigation
pp. 969-972(4)
Authors: Ritter M.; Thiede C.; Schakel U.; Schmidt M.; Alpen B.; Pascheberg U.; Mohr B.; Ehninger G.; Neubauer A.; for the AML-SHG study group

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors
pp. 973-982(10)
Authors: Pfeiffer S.; Gooding R.P.; Apperley J.F.; Goldschmidt H.; Samson D.

Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders
pp. 983-991(9)
Authors: Wattel E.; de Botton S.; Lai J.L.; Preudhomme C.; Lepelley P.; Bauters F.; Fenaux P.

Clonal stability in late-relapsing childhood lymphoblastic leukaemia
pp. 992-994(3)
Authors: Frost L.; Goodeve A.; Wilson G.; Peake I.; Barker H.; Vora A.

Sensitive non-radioactive PCR detection of clonal T-cell receptor-gamma gene rearrangements in childhood acute lymphoblastic leukaemia
pp. 995-998(4)
Authors: Haber M.; Kwan E.; Zhu L.; Marshall G.M.; Norris M.D.

Cell birth and death in childhood acute lymphoblastic leukaemia: how fast does the neoplastic cell clone expand?
pp. 999-1001(3)
Authors: Hirt A.; Leibundgut K.; Ridolfi Luthy A.; von der Weid N.; Wagner H.P.

Alpha interferon gene deletions in post-transplant lymphoma
pp. 1002-1003(2)
Authors: Wood A.; Angus B.; Kestevan P.; Dark J.; Notarianni G.; Miller S.; Howard M.; Proctor S.; Middleton P.

Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia
pp. 1004-1009(6)
Authors: Guardiola P.; Esperou H.; Cazals-Hatem D.; Ifrah N.; Jouet J.P.; Buzyn A.; Sutton L.; Gratecos N.; Tilly H.; Lioure B.; Gluckman E.

Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis
pp. 1010-1016(7)
Authors: Anderson J.E.; Sale G.; Appelbaum F.R.; Chauncey T.R.; Storb R.

Engraftment of normal stem cells in W/Wv mice assessed by a novel quantitative PCR analysis
pp. 1017-1025(9)
Authors: Tanosaki R.; Migliaccio A.R.

Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood
pp. 1026-1036(11)
Authors: Cashman J.; Bockhold K.; Hogge D.E.; Eaves A.C.; Eaves C.J.

Two cytotoxic pathways of natural killer cells in human cord blood: implications in cord blood transplantation
pp. 1037-1040(4)
Authors: Umemoto M.; Azuma E.; Hirayama M.; Nagai M.; Hiratake S.; Qi J.; Kumamoto T.; Komada Y.; Sakurai M.

BCSH GUIDELINES ON THE INSERTION AND MANAGEMENT OF CENTRAL VENOUS LINES
pp. 1041-1047(7)

Fas-MEDIATED APOPTOSIS AND p53 MUTATION IN A HODGKIN'S DISEASE CELL LINE
pp. 1048-1049(2)
Authors: Kubonishi I.; Furihata M.; Kamioka M.; Sonobe H.; Ohtsuki Y.; Miyoshi I.